Lab Notes: NRx seeks patent for Covid-19 therapy; Baudax Bio raises $4.2M

Philadelphia-area life sciences news this week includes updates on a company seeking a patent for its Covid-19 therapy, a private stock sale, and a Temple University spinout publishing its study findings on a potential treatment for NASH.

Leave a Reply